Patents by Inventor Juan I. Luengo

Juan I. Luengo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL METAL COMPLEXES
    Publication number: 20010014454
    Abstract: Invented are zinc chelated dimeric cell-surface receptor ligands, pharmaceutical compositions containing these compounds, and methods of using these compounds as agonist of dimeric cell-surface receptors. Also invented are novel processes used in preparing these compounds. Also invented are novel receptor binding moieties of the invented zinc chelated cell-surface receptor ligands.
    Type: Application
    Filed: April 27, 2000
    Publication date: August 16, 2001
    Inventors: JOHN G. GLEASON, JUAN I. LUENGO
  • Metal complexes
    Patent number: 6211200
    Abstract: Invented are zinc chelated G-CSF receptor ligands, pharmaceutical compositions containing these compounds, and methods of using these compounds as agonist of the G-CSF receptor. Also invented are novel processes used in preparing these compounds. Also invented are novel G-CSF receptor binding moieties of the invented zinc chelated G-CSF receptor ligands.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: April 3, 2001
    Assignees: SmithKline Beecham Corporation, Ligand Pharmaceuticals
    Inventors: Juan I. Luengo, Stephen G. Miller
  • 2,5-diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroim idazo[4,5-d]imidazoles which are effective as G-CSF mimetics
    Patent number: 5981551
    Abstract: Described herein are substituted 2,5-Diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimidazo[4,5-d]imidazol es of formula (I), wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are defined therein, pharmaceutical compositions containing these compounds, methods of using these compounds as G-CSF Mimetics, and processes used in preparing these compounds.
    Type: Grant
    Filed: November 20, 1998
    Date of Patent: November 9, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan I. Luengo, James A. Chan, Ann L. Breen
  • Rapamycin derivatives
    Patent number: 5362735
    Abstract: Rapamycin derivatives; pharmaceutical compositions comprising such rapamycin derivatives and pharmaceutically acceptable carriers or excipients; and methods of using such derivatives to inhibit pathogenic fungi growth inhibition, inhibit immunosuppression or treat carcinogenic tumors are disclosed.
    Type: Grant
    Filed: February 23, 1994
    Date of Patent: November 8, 1994
    Assignee: SmithKline Beecham Corporation
    Inventor: Juan I. Luengo